Together with his team at the University Medical Center in Utrecht, Dutch molecular geneticist Hans Clevers developed the world's first "intestinoids" for testing drugs on active human intestinal tissue. Since then, he adapted this technology for multiple additional human tissues. The advantages of the invention are twofold: First, intestinoids allow care providers to test even aggressive courses of treatment without hurting the patient. Second, the intestinoids allow for a "personalised medicine" approach to treatment, as they are uniquely matched to the genetic make up of one patient only.
For additional digital leasing and purchase options contact a media consultant at 800-257-5126 (press option 3) or firstname.lastname@example.org.
Length: 7 minutes
Copyright date: ©2017
Prices include public performance rights.
Not available to Home Video and Publisher customers.
Finding the Code: The Race to Seque...
Fixing the Code: Genetically Engine...
Coronavirus, Smoking, Vaping: Studi...
Augmented & Predicting My MS
The Psychedelic Drug Trial: A Cure ...
Coronavirus: How the World Is Chang...
Coronavirus: Race Against the Pande...
Stronger: The Battle Against COVID-...
1000 N West Street, Suite 1281-230
Wilmington, DE 19801
P: 800.322.8755 F: 800.678.3633
Sign Up for Special Offers!
© Films Media Group. All rights reserved.